{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:19:29Z","timestamp":1788848369069,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Young Backbone Teachers of Henan Province Colleges and Universities","award":["2024GGJS054"],"award-info":[{"award-number":["2024GGJS054"]}]},{"name":"Key Technological Breakthrough Projects in Henan Province","award":["242102310253"],"award-info":[{"award-number":["242102310253"]}]},{"name":"Key Scientific Research Projects of Henan Province Higher Education Institutions","award":["25A310024"],"award-info":[{"award-number":["25A310024"]}]},{"name":"Research Project from Pingyuan Laboratory","award":["2023PY-ZZ-0201"],"award-info":[{"award-number":["2023PY-ZZ-0201"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22271079"],"award-info":[{"award-number":["22271079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12602-025-10590-7","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:28:23Z","timestamp":1751498903000},"page":"1938-1949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-Pseudomonas aeruginosa Activity of the Scorpion-Derived Peptide GK8"],"prefix":"10.1007","volume":"18","author":[{"given":"Zhongjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shegan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"10590_CR1","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.2147\/IJN.S469724","volume":"19","author":"MI Quinones-Vico","year":"2024","unstructured":"Quinones-Vico MI, Ubago-Rodriguez A, Fernandez-Gonzalez A et al (2024) Antibiotic nanoparticles-loaded wound dressings against pseudomonas aeruginosa\u2019s skin infection: A systematic review. Int J Nanomedicine 19:7895\u20137926. https:\/\/doi.org\/10.2147\/IJN.S469724","journal-title":"Int J Nanomedicine"},{"issue":"10325","key":"10590_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(22)00087-3","volume":"399","author":"R Laxminarayan","year":"2022","unstructured":"Laxminarayan R (2022) The overlooked pandemic of antimicrobial resistance. Lancet 399(10325):606\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(22)00087-3","journal-title":"Lancet"},{"issue":"10325","key":"10590_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"C Antimicrobial Resistance","year":"2022","unstructured":"Antimicrobial Resistance C (2022) Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"issue":"18","key":"10590_CR4","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M (2021) The epidemiology and pathogenesis and treatment of pseudomonas aeruginosa infections: An update. Drugs 81(18):2117\u20132131. https:\/\/doi.org\/10.1007\/s40265-021-01635-6","journal-title":"Drugs"},{"issue":"2","key":"10590_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40121-022-00591-2","volume":"11","author":"AJ Kunz Coyne","year":"2022","unstructured":"Kunz Coyne AJ, El Ghali A, Holger D et al (2022) Therapeutic strategies for emerging multidrug-resistant pseudomonas aeruginosa. Infect Dis Ther 11(2):661\u2013682. https:\/\/doi.org\/10.1007\/s40121-022-00591-2","journal-title":"Infect Dis Ther"},{"key":"10590_CR6","doi-asserted-by":"publisher","first-page":"926758","DOI":"10.3389\/fcimb.2022.926758","volume":"12","author":"C Liao","year":"2022","unstructured":"Liao C, Huang X, Wang Q et al (2022) Virulence factors of pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance. Front Cell Infect Microbiol 12:926758. https:\/\/doi.org\/10.3389\/fcimb.2022.926758","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10590_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/microorganisms11040916","volume":"11","author":"MM Elmassry","year":"2023","unstructured":"Elmassry MM, Colmer-Hamood JA, Kopel J et al (2023) Anti-pseudomonas aeruginosa vaccines and therapies: An assessment of clinical trials. Microorganisms 11(4):916. https:\/\/doi.org\/10.3390\/microorganisms11040916","journal-title":"Microorganisms"},{"issue":"12","key":"10590_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph6121543","volume":"6","author":"AA Bahar","year":"2013","unstructured":"Bahar AA, Ren D (2013) Antimicrobial peptides. Pharmaceuticals (Basel) 6(12):1543\u20131575. https:\/\/doi.org\/10.3390\/ph6121543","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10590_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238\u2013250. https:\/\/doi.org\/10.1038\/nrmicro1098","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10590_CR10","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.3390\/ijms25084400","volume":"25","author":"ML Mangoni","year":"2024","unstructured":"Mangoni ML, Loffredo MR, Casciaro B et al (2024) An overview of frog skin-derived esc peptides: Promising multifunctional weapons against pseudomonas aeruginosa-induced pulmonary and ocular surface infections. Int J Mol Sci 25(8):4400. https:\/\/doi.org\/10.3390\/ijms25084400","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10590_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/antibiotics13070574","volume":"13","author":"X Liu","year":"2024","unstructured":"Liu X, Shi D, Cheng S et al (2024) Modification and synergistic studies of a novel frog antimicrobial peptide against pseudomonas aeruginosa biofilms. Antibiotics (Basel) 13(7):574. https:\/\/doi.org\/10.3390\/antibiotics13070574","journal-title":"Antibiotics (Basel)"},{"key":"10590_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.toxicon.2020.07.028","volume":"186","author":"Z Li","year":"2020","unstructured":"Li Z, Yuan Y, Li S et al (2020) Antibacterial activity of a scorpion-derived peptide and its derivatives in vitro and in vivo. Toxicon 186:35\u201341. https:\/\/doi.org\/10.1016\/j.toxicon.2020.07.028","journal-title":"Toxicon"},{"key":"10590_CR13","unstructured":"CLSI (2019)\u00a0Performance standards for antimicrobial susceptibility testing. In: CLSI document M100, 29th ed. https:\/\/clsi.org\/"},{"key":"10590_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2022.01.012","volume":"209","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Li S, Zhao Z et al (2022) In vitro and in vivo antibacterial activity of a lysine-rich scorpion peptide derivative. Toxicon 209:1\u20139. https:\/\/doi.org\/10.1016\/j.toxicon.2022.01.012","journal-title":"Toxicon"},{"key":"10590_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.toxicon.2022.09.004","volume":"218","author":"S Li","year":"2022","unstructured":"Li S, Shui Y, Ma J et al (2022) Antimicrobial activity of ct-k3k7, a modified peptide by lysine substitutions from ctry2459 - a chaerilus tryznai scorpion venom peptide. Toxicon 218:88\u201398. https:\/\/doi.org\/10.1016\/j.toxicon.2022.09.004","journal-title":"Toxicon"},{"issue":"5","key":"10590_CR16","doi-asserted-by":"publisher","first-page":"e97539","DOI":"10.1371\/journal.pone.0097539","volume":"9","author":"Z Li","year":"2014","unstructured":"Li Z, Xu X, Meng L et al (2014) Hp1404, a new antimicrobial peptide from the scorpion heterometrus petersii. PLoS ONE 9(5):e97539. https:\/\/doi.org\/10.1371\/journal.pone.0097539","journal-title":"PLoS ONE"},{"issue":"7","key":"10590_CR17","doi-asserted-by":"publisher","first-page":"e40135","DOI":"10.1371\/journal.pone.0040135","volume":"7","author":"L Cao","year":"2012","unstructured":"Cao L, Dai C, Li Z et al (2012) Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo. PLoS ONE 7(7):e40135. https:\/\/doi.org\/10.1371\/journal.pone.0040135","journal-title":"PLoS ONE"},{"key":"10590_CR18","doi-asserted-by":"publisher","first-page":"869650","DOI":"10.3389\/fmicb.2022.869650","volume":"13","author":"R Mirzaei","year":"2022","unstructured":"Mirzaei R, Alikhani MY, Arciola CR et al (2022) Highly synergistic effects of melittin with vancomycin and rifampin against vancomycin and rifampin resistant staphylococcus epidermidis. Front Microbiol 13:869650. https:\/\/doi.org\/10.3389\/fmicb.2022.869650","journal-title":"Front Microbiol"},{"issue":"6","key":"10590_CR19","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00284-014-0657-x","volume":"69","author":"W Lee","year":"2014","unstructured":"Lee W, Lee DG (2014) Magainin 2 induces bacterial cell death showing apoptotic properties. Curr Microbiol 69(6):794\u2013801. https:\/\/doi.org\/10.1007\/s00284-014-0657-x","journal-title":"Curr Microbiol"},{"issue":"4","key":"10590_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/pharmaceutics13040438","volume":"13","author":"J Shi","year":"2021","unstructured":"Shi J, Chen C, Wang D et al (2021) Amphipathic peptide antibiotics with potent activity against multidrug-resistant pathogens. Pharmaceutics 13(4):438. https:\/\/doi.org\/10.3390\/pharmaceutics13040438","journal-title":"Pharmaceutics"},{"issue":"16","key":"10590_CR21","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1128\/JB.00594-08","volume":"190","author":"WJ Gooderham","year":"2008","unstructured":"Gooderham WJ, Bains M, McPhee JB et al (2008) Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of psra in pseudomonas aeruginosa. J Bacteriol 190(16):5624\u20135634. https:\/\/doi.org\/10.1128\/JB.00594-08","journal-title":"J Bacteriol"},{"issue":"1","key":"10590_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12866-020-01889-2","volume":"20","author":"T Chen","year":"2020","unstructured":"Chen T, Xu Y, Xu W et al (2020) Hypertonic glucose inhibits growth and attenuates virulence factors of multidrug-resistant pseudomonas aeruginosa. BMC Microbiol 20(1):203. https:\/\/doi.org\/10.1186\/s12866-020-01889-2","journal-title":"BMC Microbiol"},{"issue":"6","key":"10590_CR23","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1093\/nar\/gkad059","volume":"51","author":"X Pan","year":"2023","unstructured":"Pan X, Liang H, Zhao X et al (2023) Regulatory and structural mechanisms of pvra-mediated regulation of the pqs quorum-sensing system and pha biosynthesis in pseudomonas aeruginosa. Nucleic Acids Res 51(6):2691\u20132708. https:\/\/doi.org\/10.1093\/nar\/gkad059","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10590_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3892\/etm.2014.2120","volume":"9","author":"ZG Xu","year":"2015","unstructured":"Xu ZG, Gao Y, He JG et al (2015) Effects of azithromycin on pseudomonas aeruginosa isolates from catheter-associated urinary tract infection. Exp Ther Med 9(2):569\u2013572. https:\/\/doi.org\/10.3892\/etm.2014.2120","journal-title":"Exp Ther Med"},{"issue":"6","key":"10590_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/jobm.201100292","volume":"52","author":"KS Musthafa","year":"2012","unstructured":"Musthafa KS, Balamurugan K, Pandian SK et al (2012) 2,5-piperazinedione inhibits quorum sensing-dependent factor production in pseudomonas aeruginosa pao1. J Basic Microbiol 52(6):679\u2013686. https:\/\/doi.org\/10.1002\/jobm.201100292","journal-title":"J Basic Microbiol"},{"issue":"21","key":"10590_CR26","doi-asserted-by":"publisher","first-page":"13494","DOI":"10.3390\/ijms232113494","volume":"23","author":"M Artini","year":"2022","unstructured":"Artini M, Imperlini E, Buonocore F et al (2022) Anti-virulence potential of a chionodracine-derived peptide against multidrug-resistant pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. Int J Mol Sci 23(21):13494. https:\/\/doi.org\/10.3390\/ijms232113494","journal-title":"Int J Mol Sci"},{"key":"10590_CR27","doi-asserted-by":"publisher","first-page":"105166","DOI":"10.1016\/j.micpath.2021.105166","volume":"160","author":"W Zhang","year":"2021","unstructured":"Zhang W, Yuan Y, Li S et al (2021) Comparative transcription analysis of resistant mutants against four different antibiotics in pseudomonas aeruginosa. Microb Pathog 160:105166. https:\/\/doi.org\/10.1016\/j.micpath.2021.105166","journal-title":"Microb Pathog"},{"issue":"10","key":"10590_CR28","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/ph16101356","volume":"16","author":"I Jahan","year":"2023","unstructured":"Jahan I, Kumar SD, Shin SY et al (2023) Multifunctional properties of bmap-18 and its aliphatic analog against drug-resistant bacteria. Pharmaceuticals (Basel) 16(10):1356. https:\/\/doi.org\/10.3390\/ph16101356","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10590_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4149\/gpb_2009_02_105","volume":"28","author":"K Lohner","year":"2009","unstructured":"Lohner K (2009) New strategies for novel antibiotics: Peptides targeting bacterial cell membranes. Gen Physiol Biophys 28(2):105\u2013116. https:\/\/doi.org\/10.4149\/gpb_2009_02_105","journal-title":"Gen Physiol Biophys"},{"issue":"1","key":"10590_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2011","unstructured":"Fjell CD, Hiss JA, Hancock RE et al (2011) Designing antimicrobial peptides: Form follows function. Nat Rev Drug Discov 11(1):37\u201351. https:\/\/doi.org\/10.1038\/nrd3591","journal-title":"Nat Rev Drug Discov"},{"issue":"22","key":"10590_CR31","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1111\/j.1742-4658.2009.07359.x","volume":"276","author":"P Nicolas","year":"2009","unstructured":"Nicolas P (2009) Multifunctional host defense peptides: Intracellular-targeting antimicrobial peptides. FEBS J 276(22):6483\u20136496. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07359.x","journal-title":"FEBS J"},{"issue":"18","key":"10590_CR32","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M (2021) The epidemiology and pathogenesis and treatment of infections: An update. Drugs 81(18):2117\u20132131. https:\/\/doi.org\/10.1007\/s40265-021-01635-6","journal-title":"Drugs"},{"issue":"3","key":"10590_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/Pathogens11030300","volume":"11","author":"FF Tuon","year":"2022","unstructured":"Tuon FF, Dantas LR, Suss PH et al (2022) Pathogenesis of the biofilm: A review. Pathogens 11(3):300. https:\/\/doi.org\/10.3390\/Pathogens11030300","journal-title":"Pathogens"},{"issue":"10","key":"10590_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/antibiotics11101366","volume":"11","author":"A Alqahtani","year":"2022","unstructured":"Alqahtani A, Kopel J, Hamood A (2022) The in vivo and in vitro assessment of pyocins in treating infections. Antibiotics-Basel 11(10):1366. https:\/\/doi.org\/10.3390\/antibiotics11101366","journal-title":"Antibiotics-Basel"},{"issue":"5","key":"10590_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00005-018-0510-1","volume":"66","author":"VFL Yong","year":"2018","unstructured":"Yong VFL, Soh MM, Jaggi TK et al (2018) The microbial endocrinology of\u202f: Inflammatory and immune perspectives. Arch Immunol Ther Exp 66(5):329\u2013339. https:\/\/doi.org\/10.1007\/s00005-018-0510-1","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"10590_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/Cmr.00036-10","volume":"24","author":"AR Hauser","year":"2011","unstructured":"Hauser AR, Jain M, Bar-Meir M et al (2011) Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 24(1):29\u201370. https:\/\/doi.org\/10.1128\/Cmr.00036-10","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10590_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1165\/rcmb.2017-0321TR","volume":"58","author":"NM Maurice","year":"2018","unstructured":"Maurice NM, Bedi B, Sadikot RT (2018) Biofilms: Host response and clinical implications in lung infections. Am J Respir Cell Mol Biol 58(4):428\u2013439. https:\/\/doi.org\/10.1165\/rcmb.2017-0321TR","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-025-10590-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-025-10590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:59:20Z","timestamp":1774342760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-025-10590-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10590"],"URL":"https:\/\/doi.org\/10.1007\/s12602-025-10590-7","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"9 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Male BALB\/c mice (20\u201330 g) were obtained from Henan SKBEX Biology Co., Ltd., and the China Science and Technology Resource identification of the mice was CSTR:15497.09.N000009. (\n                      \n                      ). All the animal-associated experiments were conducted following the Animal Care Ethics guidelines with protocols approved by the Animal Care and Use Committee of Henan University of Technology and Science. The mice were maintained under a standard condition of humidity (50 \u00b1\u20095%), temperature (25 \u00b1\u20092 \u00baC) and dark\u2013light cycles (12 h each) with free access to food and water. The mice were humanely euthanized (anesthetized by intra-peritoneal pentobarbital injection and sacrificed by cervical dislocation) at the end of the experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}